REQUEST A DEMO
Total
USD $0.00
Search more companies

Escollanos Medicamentos Biologicos CIA Ltda (Ecuador)

Main Activities: Pharmacies and Drug Stores
Full name: Escollanos Medicamentos Biologicos CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Escollanos Medicamentos Biologicos CIA Ltda is a medical company that specializes in natural therapies and homeopathic products. They offer a comprehensive range of medical products and inserts for different integrative therapies and have developed a digital platform to support doctors in their daily consultations.

Headquarters
Juan de Sosaya Oe4-54, Escollanos Bldg.
Quito; Pichincha;

Contact Details: Purchase the Escollanos Medicamentos Biologicos CIA Ltda report to view the information.

Website: http://www.escollanos.com

Basic Information
Total Employees:
Purchase the Escollanos Medicamentos Biologicos CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Escollanos Medicamentos Biologicos CIA Ltda report to view the information.
Registered Capital:
Purchase the Escollanos Medicamentos Biologicos CIA Ltda report to view the information.
Incorporation Date:
June 23, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Escollanos Medicamentos Biologicos CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
5.57%
Total operating revenue
5.57%
Operating profit (EBIT)
-71.39%
EBITDA
-68.47%
Net Profit (Loss) for the Period
2.62%
Total assets
14.96%
Total equity
12.07%
Operating Profit Margin (ROS)
-22.04%
Net Profit Margin
-0.08%
Return on Equity (ROE)
-0.99%
Debt to Equity Ratio
1.67%
Quick Ratio
-0.01%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?